Pharmaceutical Technology

FEBRUARY 8, 2023

Genenta Science and AGC Biologics have signed a development and manufacturing service agreement (MSA). Under the deal, AGC Biologics will be responsible for manufacturing the cell therapy lentivirus-based product for the ongoing clinical programmes of Genenta Science.

Manufacturing 52

Manufacturing Pharmaceutical Medicine Management 52

Pharmaceutical Technology

AUGUST 17, 2022

Biopharmaceutical contract development and manufacturing organisation (CDMO) AGC Biologics has entered a strategic collaboration with RoosterBio to expedite the manufacturing of cell and exosome therapies. It will also have the potential to scale to Phase III clinical development and commercial manufacturing.

Manufacturing 52

Manufacturing Networking Media Engineering 52

European Pharmaceutical Review

OCTOBER 5, 2023

Ahead of her presentation on the future of biomanufacturing at CPHI Barcelona, Sheila Ann Mikhail, the co-founder and former CEO of AskBio, engages in a conversation about gene therapy, artificial intelligence, and the importance of being a well-informed innovator when selecting a manufacturing partner.

Manufacturing 82

Manufacturing Consulting Patients Marketing 82

Pharmaceutical Technology

JUNE 2, 2023

As we look to find new and better ways to treat ophthalmic diseases, we want to get it right and ensure that our product candidates can be scaled up appropriately for each development stage and, ultimately, for commercialisation. The company is a global contract development and manufacturing organisation (CDMO) for biopharmaceuticals.

Biopharma 52

Biopharma Manufacturing Leads Pharmaceutical 52

European Pharmaceutical Review

OCTOBER 2, 2023

It provides unparalleled opportunities to source valuable partnerships, secure contracts, and stay ahead in a rapidly evolving industry. Attendees can plan meetings, bookmark interesting exhibitions and products, and receive personalised recommendations from AI regarding products, exhibitions and relevant content sessions.

Manufacturing 96

Manufacturing Pharma Engineering Networking 96

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. He questioned how regulators will enforce revisions to Good Manufacturing Practice (GMP) regulations.

Pharmaceutical 125

Pharmaceutical Food and Drug Administration Manufacturing FDA 125

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. Despite having large biopharmaceutical companies on home ground, the UK and France experienced major shortages and supply chain issues.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Government Pharmaceutical 105